Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Align Technology
ALGN
|
+$420M |
| 2 |
Walt Disney
DIS
|
+$412M |
| 3 |
Deere & Co
DE
|
+$405M |
| 4 |
Icon
ICLR
|
+$400M |
| 5 |
Freeport-McMoran
FCX
|
+$276M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$972M |
| 2 |
Amazon
AMZN
|
+$636M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$391M |
| 4 |
Microsoft
MSFT
|
+$380M |
| 5 |
Aon
AON
|
+$316M |
Sector Composition
| 1 | Technology | 30.67% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
NIO
NIO
$14B
| $3.19M | ﹤0.01% |
89,630
+399
| +0.4% | +$14.2K |
|
1152
Corcept Therapeutics
CORT
$7.68B
| $3.18M | ﹤0.01% |
161,342
-30,276
| -16% | -$596K |
|
1153
MarketAxess Holdings
MKTX
$6.91B
| $3.15M | ﹤0.01% |
7,500
-6,284
| -46% | -$2.64M |
|
|
CMRX
1154
DELISTED
Chimerix, Inc.
CMRX
| $3.15M | ﹤0.01% |
+507,703
| New | +$3.15M |
|
1155
Eastman Chemical
EMN
$7.71B
| $3.14M | ﹤0.01% |
31,173
-1,875
| -6% | -$189K |
|
1156
Boston Properties
BXP
$12.2B
| $3.1M | ﹤0.01% |
28,643
-7,268
| -20% | -$787K |
|
1157
SEI Investments
SEIC
$10.7B
| $3.1M | ﹤0.01% |
52,187
-2,375
| -4% | -$141K |
|
1158
Pembina Pipeline
PBA
$22.8B
| $3.09M | ﹤0.01% |
97,399
-21,199
| -18% | -$673K |
|
1159
Vanguard High Dividend Yield ETF
VYM
$65B
| $3.06M | ﹤0.01% |
29,632
-5,432
| -15% | -$561K |
|
1160
CenterPoint Energy
CNP
$25B
| $3.06M | ﹤0.01% |
124,325
-71,509
| -37% | -$1.76M |
|
1161
Masimo
MASI
$8.01B
| $3.02M | ﹤0.01% |
11,150
-20,840
| -65% | -$5.64M |
|
1162
W.P. Carey
WPC
$15B
| $3.02M | ﹤0.01% |
42,179
-11,650
| -22% | -$833K |
|
1163
Trex
TREX
$6.48B
| $2.96M | ﹤0.01% |
29,052
-28,477
| -50% | -$2.9M |
|
1164
Arch Capital
ACGL
$34.4B
| $2.96M | ﹤0.01% |
77,420
-48,485
| -39% | -$1.85M |
|
1165
Pinnacle West Capital
PNW
$10.5B
| $2.94M | ﹤0.01% |
40,597
-96,912
| -70% | -$7.01M |
|
|
KNTE
1166
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.92M | ﹤0.01% |
127,027
-475,709
| -79% | -$10.9M |
|
1167
Silgan Holdings
SLGN
$4.71B
| $2.92M | ﹤0.01% |
76,001
-15,693
| -17% | -$602K |
|
1168
Royal Gold
RGLD
$12.5B
| $2.91M | ﹤0.01% |
+30,511
| New | +$2.91M |
|
1169
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$55B
| $2.91M | ﹤0.01% |
30,775
-398
| -1% | -$37.6K |
|
1170
Markel Group
MKL
$24.7B
| $2.89M | ﹤0.01% |
2,413
-390
| -14% | -$467K |
|
1171
NVR
NVR
$23.3B
| $2.84M | ﹤0.01% |
591
-367
| -38% | -$1.76M |
|
1172
Savara
SVRA
$615M
| $2.82M | ﹤0.01% |
2,034,586
| – | – |
|
1173
A.O. Smith
AOS
$10.2B
| $2.82M | ﹤0.01% |
46,123
+24,621
| +115% | +$1.5M |
|
1174
RH
RH
$4.08B
| $2.8M | ﹤0.01% |
4,197
+1,756
| +72% | +$1.17M |
|
|
COUP
1175
DELISTED
Coupa Software Incorporated
COUP
| $2.8M | ﹤0.01% |
12,760
-1,241
| -9% | -$272K |
|